NRIX Nurix Therapeutics, Inc.
Nasdaq · SEC CIK 1549595 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.53M 32 sales by 3 insiders
- Filings on record
- 197 since 2021-07-02, latest 2026-09-02 19:42
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ring Christine | CLO | — | $3.26M |
| van Houte Hans | CFO | — | $635.3K |
| Hansen Gwenn | CSO | — | $630.9K |
Transactions 233
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-02 | 2021-12-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $29.13 | -400 | 14.2K | -3% | -$11.7K |
| D | 2021-11-12 | 2021-11-10 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2021-11-12 | 2021-11-10 | NRIX | Ring Christine | GC | S - Sale+OE | $32.38 | -1,200 | 1,286 | -48% | -$38.9K |
| D | 2021-11-02 | 2021-11-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $33.24 | -400 | 14.2K | -3% | -$13.3K |
| D | 2021-11-02 | 2021-11-01 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.6K | +3% | +$2,904 |
| D | 2021-10-28 | 2021-10-27 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +800 | 2,086 | +62% | +$1,488 |
| D | 2021-10-28 | 2021-10-27 | NRIX | Ring Christine | GC | S - Sale+OE | $35.25 | -800 | 1,286 | -38% | -$28.2K |
| D | 2021-10-28 | 2021-10-27 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.6K | +3% | +$2,904 |
| D | 2021-10-28 | 2021-10-27 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $35.00 | -400 | 14.2K | -3% | -$14.0K |
| D | 2021-10-12 | 2021-10-11 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2021-10-12 | 2021-10-11 | NRIX | Ring Christine | GC | S - Sale+OE | $27.36 | -1,200 | 1,286 | -48% | -$32.8K |
| D | 2021-10-04 | 2021-10-01 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.6K | +3% | +$2,904 |
| D | 2021-10-04 | 2021-10-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $29.92 | -400 | 14.2K | -3% | -$12.0K |
| D | 2021-09-13 | 2021-09-10 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +2,000 | 3,286 | +156% | +$3,720 |
| DM | 2021-09-13 | 2021-09-10 | NRIX | Ring Christine | GC | S - Sale+OE | $35.93 | -2,000 | 1,286 | -61% | -$71.9K |
| D | 2021-09-08 | 2021-09-07 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +1,600 | 15.8K | +11% | +$11.6K |
| D | 2021-09-08 | 2021-09-07 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $35.00 | -1,600 | 14.2K | -10% | -$56.0K |
| D | 2021-09-08 | 2021-09-07 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +3,200 | 4,486 | +249% | +$5,952 |
| D | 2021-09-08 | 2021-09-07 | NRIX | Ring Christine | GC | S - Sale+OE | $35.25 | -3,200 | 1,286 | -71% | -$112.8K |
| D | 2021-09-02 | 2021-09-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $32.34 | -400 | 14.2K | -3% | -$12.9K |
| D | 2021-09-02 | 2021-09-01 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.6K | +3% | +$2,904 |
| D | 2021-08-11 | 2021-08-10 | NRIX | Beaurang Pierre | Chief Business Off | M - OptEx | $1.11 | +7,500 | 11.8K | +173% | +$8,325 |
| DM | 2021-08-11 | 2021-08-10 | NRIX | Beaurang Pierre | Chief Business Off | S - Sale+OE | $29.86 | -7,500 | 6,210 | -55% | -$223.9K |
| D | 2021-08-11 | 2021-08-10 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,005 | +149% | +$2,232 |
| D | 2021-08-11 | 2021-08-10 | NRIX | Ring Christine | GC | S - Sale+OE | $29.87 | -1,200 | 805 | -60% | -$35.8K |
| D | 2021-08-03 | 2021-08-02 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.2K | +3% | +$2,904 |
| D | 2021-08-03 | 2021-08-02 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $31.21 | -400 | 13.8K | -3% | -$12.5K |
| D | 2021-07-21 | 2021-07-20 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,005 | +149% | +$2,232 |
| D | 2021-07-21 | 2021-07-20 | NRIX | Ring Christine | GC | S - Sale+OE | $27.00 | -1,200 | 805 | -60% | -$32.4K |
| DM | 2021-07-12 | 2021-07-12 | NRIX | Beaurang Pierre | Chief Business Off | S - Sale+OE | $23.93 | -7,500 | 4,730 | -61% | -$179.4K |
| D | 2021-07-12 | 2021-07-12 | NRIX | Beaurang Pierre | Chief Business Off | M - OptEx | $1.11 | +7,500 | 11.8K | +173% | +$8,325 |
| D | 2021-07-02 | 2021-07-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $26.76 | -400 | 13.8K | -3% | -$10.7K |
| D | 2021-07-02 | 2021-07-01 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.2K | +3% | +$2,904 |
Purchase Sale Sale after option exercise All abbreviations